Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 54.73 - -
Change - -45.55% -68.19% 94.7% -51.15% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 54.73 54.73 54.73
Change - -45.55% -68.19% 94.7% -51.15% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 45.6x 42.1x 34.2x
EV / Revenue - 0x 0x 0x 45.6x 42.1x 34.2x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -8.42x -8.55x -
EV / FCF - -0x - -0x -8.55x -15.2x -14x
FCF Yield - -9.52% - -4.08% -11.7% -6.58% -7.13%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.6840 0.6840 0.6840
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 3/1/23 5/15/24 5/13/25 5/13/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 62.37M
108.24x6.03x25.59x2.29% 367B
22.86x3.09x10.81x1.74% 66.89B
15.8x7.7x11.8x - 12.93B
14.47x1.8x6.12x3.06% 7.54B
17.92x5.57x14.88x-.--% 4.38B
35.37x2.32x26.43x0.78% 4.07B
34.7x5.43x15.9x - 3.02B
-213.3x - - -.--% 2.48B
Average 4.51x 4.56x 15.93x 1.31% 52.05B
Weighted average by Cap. 88.33x 5.55x 22.61x 2.18%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. AB Stock
  4. Valuation AB Science